Report Code: A12058 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Oncology Clinical Trials Market
Request Now !Oncology clinical trials involve the advancement of new treatments for various cancers, and oncology is somewhat more complex than other therapeutic areas. An oncology trial not only examines the efficacy and safety of an antibiotic against infection but also tries to develop and enhance the subject's quality of life. For the management of cancer, research is progressing at a rapid pace, hence a shift has been observed for immunotherapy from chemotherapy protocols to molecularly targeted agents. Sharp growths in available clinical data, as well as a strong and growing pipeline of drug candidates, are the major trends involved in the evolution of oncology clinical trials.
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the oncology clinical trials market.
Top Impacting Factors
Market Trends
New product launches to flourish the market
In June 2018, Synexus and Acurian collaboratively launched SynexusPlus, it is a solution for patient enrollment in clinical studies and is expected to raise clinical trial productivity.
In September 2019, a collaboration with Cancer Researchers was declared by IQVIA to advance the use of real-world data and extend clinical research in oncology.
In Jul 2020, a phase III clinical trial of alpelisib in combination with pertuzumab and trastuzumab was commenced by Novartis AG to evaluate the safety and efficacy to use as maintenance treatment for patients with HER2-positive advanced breast cancer.
In Mar 2021, phase II clinical trial of fixed-dose co-formulated pembrolizumab/quavonlimab (MK-1308A) plus lenvatinib began by Dohme Corp. and Merck Sharp to estimate the efficacy and safety in patients with hepatocellular carcinoma (HCC).
Key Benefits of the Report
Questions answered in the Oncology Clinical Trials Report
Oncology Clinical Trials Market Report Highlights
Aspects | Details |
---|---|
By Phase |
|
By Study Design |
|
By Cancer Type |
|
By Region |
|
Key Market Players | PAREXEL International Corporation,, Merck & Co Inc.,, Medpace, F. Hoffmann-La Roche Ltd,, Novotech,, Novartis AG,, Bristol Myers Squibb company,, Pivotal,, Syneos Health, PRA Health Sciences, |
Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers